Home Newsfeeds Genius Brands Grows ‘Stan Lee’ Business For Centennial Celebration

News

Genius Brands Grows ‘Stan Lee’ Business For Centennial Celebration

"Stan Lee" Documentary to Premiere on Disney+ in 2023 Stan Lee Online Store Launches, Featuring a Branded Product Collection

byBenzinga Newsdesk

December 28, 2022

1 minute read

“Stan Lee” Documentary to Premiere on Disney+ in 2023

Stan Lee Online Store Launches, Featuring a Branded Product Collection

Village Farms Q1 FY23 Sales Decline 8% YoY, What About Adjusted EBITDA?

By Vuk Zdinjak

May 10, 9:11 AM

Village Farms International, Inc. (NASDAQ: VFF) released its financial results for the first quarter ended March 31, 2023, revealing sales decreased 8% year-over-year to $64.7 million from $70.2 million.

VFF

BNB Chain Is Now Operational After Suspension Due To A Cross-Chain Exploit

By Murtuza Merchant

October 8, 11:21 AM

The BNB chain (CRYPTO: BNB), the native cryptocurrency that powers the Binance exchange, was operational after being suspended temporarily following a major exploit of around $100 million.

$BNB

High-Yielding ManpowerGroup Inc. Goes On Sale

By MarketBeat

July 19, 11:07 AM

ManpowerGroup (NYSE: MAN) certainly had a mixed quarter but the news is more bullish than not. While the revenue and earnings both fell short of the Marketbeat.com consensus estimates margins widened, cash flow was strong, shares were repurchased, and the dividend was paid.

MAN

Allarity Outlines Steps To Accelerate Delayed Recruitment In Ixempra, Stenoparib Cancer Trials

By Vandana Singh

March 28, 7:12 AM

Allarity Therapeutics Inc (NASDAQ:ALLR) said that for Ixempra and stenoparib monotherapy trials, Allarity is taking steps to accelerate patient recruitment to…

ALLR

Genius Brands Grows ‘Stan Lee’ Business For Centennial Celebration

Related Posts

Village Farms Q1 FY23 Sales Decline 8% YoY, What About Adjusted EBITDA?

BNB Chain Is Now Operational After Suspension Due To A Cross-Chain Exploit

High-Yielding ManpowerGroup Inc. Goes On Sale

Allarity Outlines Steps To Accelerate Delayed Recruitment In Ixempra, Stenoparib Cancer Trials